development related to infectious diseases like HIV is expected to provide positive outlook for African
immunotherapy market during the forecast period. Moreover, the need for alternative treatment for cancer,
autoimmune, inflammatory and other diseases in developing countries in Africa is expected to provide
growth opportunities for the market players. Presence of good healthcare facilities in Middle East is expected
to provide opportunities for the growth of demand for immunotherapy drugs, if there is a significant
reduction in the prices during the forecast period.
Companies Profiled:
Hoffmann-La Roche AG,
Merck & Co., Inc.,
Novartis International AG,
Johnson & Johnson,
GlaxoSmithKline PLC,
Amgen Inc,
AstraZeneca PLC,
Bristol-Myers Squibb,
Galena Biopharma,
Inovio Pharmaceuticals.
Infinium Global Research